| 261/432 | US=18 / Dor/Paliativo Liben S, Lissauer T. Delivery of care: intensive care units. In: Goldman A, Hain R, Liben S. Oxford textbook of palliative medicine for children. New York: Oxford University Press, 2007. p. 549-56. ISBN 0-19-852653-7. CUIDADOS PALIATIVOS; PRESTACAO DE CUIDADOS; UNIDADES DE TERAPIA INTENSIVA; CUIDADOS INTENSIVOS NEONATAIS; MORTE |
| 262/432 | US=20 / Dor/Paliativo Rousseau P. Other issues in palliative care: management of symptoms in the actively dying patient. In: Berger AM, Shuster Jr JL, von Roenn JH. Principles and practice of palliative care and supportive oncology. Philadelphia: Lippincott Williams & Wilkins, 2007. p. 623-32. ISBN 0-7817-9595-8. CANCER; FIM DA VIDA; CUIDADOS PALIATIVOS; MANEJO DOS SINTOMAS; DISPNEIA; ESTERTOR DA MORTE; ANSIEDADE; AGITACAO; DELIRIO; VOMITO; NAUSEA; DOR; SEDACAO PALIATIVA |
| 263/432 | US=20 / Dor/Paliativo Supanich BA. Ethical considerations in palliative care: palliative care and physician-assisted death. In: Berger AM, Shuster Jr JL, von Roenn JH. Principles and practice of palliative care and supportive oncology. 3ª ed. Philadelphia: Lippincott Williams & Wilkins, 2007. p. 707-15. ISBN 0-7817-9595-8. CANCER; ETICA; CUIDADOS PALIATIVOS; MORTE ASSISTIDA POR MEDICO |
| 264/432 | US=26 / Dor/Paliativo Etxeburu IS. La participación de la familia en la egonía y tras el fallecimiento del paciente. In: Astudillo W, Orbegozo A, Bilbao, Albo ED, Bilbão ZP. Los cuidados paliativos, una labor de todos. San Sebastian: Sociedad Vasca de Cuidados Paliativos, 2007. p. 215-30. ISBN 978-84-933596-3-8. |
| 265/432 | US=26 / Dor/Paliativo Echeburúa E, Corral P. Cómo sobrellevar mejor el proceso de duelo?. In: Astudillo W, Orbegozo A, Díaz-Albo E, Bilbão PZ. Los cuidados paliativos, una labor de todos. San Sebastian: Sociedad Vasca de Cuidados Paliativos, 2007. p. 231-46. ISBN 978-84-933596-3-8. |
| 266/432 | US=49 / Câncer Krammer PH, Kaminski M, KieBling M. No life without death. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2007. p. 111-38. ISBN 978-0-12-006697-1. VIDA; MORTE; VIDA SEM MORTE; APOPTOSE NA VIDA; APOPTOSE NA DOENCA; HIV |
| 267/432 | US=49-B / Câncer Klein G, Imreh S, Zabarovsky ER. Foundations in cancer research: why do we not all die of cancer at an early age?. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2007. p. 2-16. ISBN 978-0-12-373896-7. CANCER X MORTE; VIGILANCIA IMUNOLOGICA; VIGILANCIA GENETICA; VIGILANCIA INTRACELULAR |
| 268/432 | US=77-J / Câncer Araújo Júnior RF, Moraes GM, Otake AH. Apoptose e outras formas de morte celular. In: Lopes A, Chammas R, Iyeyasu H. Oncologia para a graduação. 3ª ed. São Paulo: Lemar, 2013. p. 105-11. ISBN 8-5866523-7-0. CANCER; APOPTOSE; MORTE CELULAR; AUTOFAGIA; NECROSE; MITOSE CATASTROFICA |
| 269/432 | US=7 / Patologia King TC. Lesão celular, resposta celular à lesão e morte celular. In: ___. Patologia. Rio de Janeiro: Elsevier, 2007. p. 1-20. (Série Elsevier de Formação Básica Integrada) ISBN 85-3522349-1. MECANISMOS DE LESAO CELULAR; HIPOXIA; ISQUEMIA; LESAO ISQUEMICA; LESAO INDUZIDA POR RADICAIS LIVRES; LESAO INFLAMATORIA; LESAO INFECCIOSA; LESAO FISICA; LESAO QUIMICA; LESAO NUTRICIONAL; LESAO GENETICA; ENVELHECIMENTO CELULAR; RESPOSTA CELULAR; HIPERPLASIA; HIPERTROFIA; ATROFIA; METAPLASIA; DISPLASIA; APOPTOSE; NECROSE CELULAR |
| 271/432 | US=92 / Biol/Mol Ricci MS, El-Deiry WS. Apoptosis and alternative modes of cell death: the extrinsic pathway of apoptosis. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 31-54. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. APOPTOSE; TNF; FAS; TRAIL; NF-KB; QUIMIOTERAPIA; RECEPTOR MORTE; RECEPTOR CHAMARIZ; VIA EXTRINSECA; AUTOIMUNIDADE |
| 272/432 | US=92 / Biol/Mol Djavaheri-Mergny M, Botti J, Codogno P. Apoptosis and alternative modes of cell death: autophagy and autophagic cell death. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 93-107. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. AUTOFAGIA; APOPTOSE; MORTE CELULAR; CANCER; MACROAUTOPHAGY; LISOSSOMO; TRANSDUCAO DE SINAL |
| 273/432 | US=92 / Biol/Mol Houghton JA. Established cancer therapies: antimetabolites. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 361-82. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. ANTIMETABOLITES; MORTE CELULAR; APOPTOSE; CATASTROFE MITOTICA; NECRESIS; SENESCENCIA |
| 274/432 | US=92 / Biol/Mol Larsen AK, Skladanowski A. Established cancer therapies: perturbations of cellular functions by topoisomerase II inhibitors. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 407-22. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TOPOISOMERASE II; AGENTES ANTICANCERIGENOS; DOXORRUBICINA; ETOPOSIDE; MORTE CELULAR; PARADA DO CRESCIMENTO; APOPTOSE; NECROSE; CATASTRIOHE MITOTICO; INDUZIDA POR DROGAS PSEUDOSENESCENCE; AUTOFAGIA |
| 275/432 | US=10 / Biol/Mol Pelengaris S, Khan M. Apoptosis. In: ___. The molecular biology of cancer. Oxford: Blackwell, 2006. p. 251-78. ISBN 978-1-4051-1814-9. FORMACAO DE CANCER; APOPTOSE CONTRA NECROSE; SUPRESSOR TUMORAL P53; MORTE CELULAR |
| 276/432 | US=12-C / Biol/Mol Alberts B, Bray D, Hopkin K, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Controle do ciclo celular e morte celular. In: ___. Fundamentos da biologia celular. 2ª ed. Porto Alegre: Artmed, 2006. p. 611-36. ISBN 85-3630679-7. CICLO CELULAR; MORTE CELULAR; CICLINAS; CDKS; MORTE CELULAR PROGRAMADA; APOPTOSE |
| 277/432 | US=17 / Biol/Mol Kiaris H. Basic aspects: the cell's life and death: cell cycle, senescence and apoptosis. In: ___. Understanding carcinogenesis: an introduction to the molecular basis of cancer. Weinheim: Wiley-VCH, 2006. p. 5-13. ISBN 978-3-527-31486-7. CICLO CELULAR; SENESCENCIA; APOPTOSE; MORTE CELULAR; APOPTOSE CONTRA NECROSE |
| 278/432 | US=2 / Biol/Mol Gülow K, Kaminski M, Krammer PH. Death receptor: the role of CD95/CD95 ligand signaling in apoptosis and cancer. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 3-30. ISBN 978-3-527-31237-5. RECEPTOR MORTE; SISTEMA CD95; SISTEMA CD95L; SINALIZACAO DA APOPTOSE; CANCER; MAQUINARIA APOPTOTICA; VIA INTRINSECA; VIA EXTRINSECA; MITOCONDRIAS; MECANISMOS DE RESISTENCIA; ANGIOGENESE |
| 279/432 | US=2 / Biol/Mol Walczak H, Koschny R, Willen D, Schader MB, Sykora J, Ganten TM, Haas TL. Death receptor: the TRAIL receptor-ligand system: biochemistry of apoptosis induction, therapeutic potential for cancer treatment and physiological function. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 31-92. ISBN 978-3-527-31237-5. RECEPTOR MORTE; SISTEMA DE RECEPTOR-LIGANTE TRAIL; BIOQUIMICA DA INDUCAO DE APOPTOSE; POTENCIAL TERAPEUTICO; CANCER. TERAPIA; FUNCAO FISIOLOGICA; ATIVACAO DA CASPASE; FAMILIA BCL-2; UBIQUITINA; TERAPIA GENETICA; INFECCAO VIRAL; IMUNOPATOLOGIAS; DOENCAS AUTO-IMUNES; TRANSPLANTE ALOGENICO DE CELULAS-TRONCO HEMATOPOETICAS |
| 280/432 | US=2 / Biol/Mol Wajant H. Death receptor: mechanisms of tumor necrosis factor-induced cell death. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 93-119. ISBN 978-3-527-31237-5. RECEPTOR DE MORTE; MORTE CELULAR; FATOR DE NECROSE TUMORAL; APOPTOSE; CANCER. TERAPIA |